© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 18, 1406-1414,
September 18, 2002
© 2002 Oxford University Press
ARTICLE |
A Prospective Study of High-Grade Cervical Neoplasia Risk Among Human Papillomavirus-Infected Women
Affiliations of authors: P. E. Castle, S. Wacholder, M. E. Sherman, M. Schiffman, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD; A. T. Lorincz, Digene Corporation, Gaithersburg, MD; D. R. Scott, A. G. Glass, B. B. Rush, Kaiser Permanente, Portland, OR; J. E. Schussler, Information Management Services, Silver Spring, MD.
Correspondence to: Philip E. Castle, Ph.D., M.P.H., National Cancer Institute, Division of Cancer Epidemiology and Genetics, 6120 Executive Blvd., Rm. 7074, MSC 7234, Rockville, MD 20892-7234 (e-mail: castlep{at}mail.nih.gov).
Background: In case–control studies, smoking, parity, and oral contraceptive use have been associated with an increased risk of cervical intraepithelial neoplasia grade 3 (CIN3) and cervical cancer among women who are infected with oncogenic human papillomavirus (HPV). However, these potential risk factors have not been adequately studied in prospective studies. Methods: We studied 1812 women who were enrolled in a 10-year prospective study of cervical neoplasia at Kaiser Permanente in Portland, Oregon, and who at enrollment had tested positive for oncogenic HPV DNA and had responded to a questionnaire that included questions on smoking, oral contraceptive use, and parity. Absolute risks and crude relative risks (RRs) with 95% confidence intervals (CIs) for CIN3 or cervical cancer were computed for three time intervals (0–8, 9–68, and 69–122 months after enrollment) using the Kaplan–Meier method. Conditional logistic regression models were used to control for factors that may have influenced our risk estimates, specifically the cytologic interpretation of baseline Pap smear, number of Pap smears during follow-up, age at enrollment, age at prediagnosis visit, and age at diagnosis. All statistical tests were two-sided. Results: Oral contraceptive use and parity were not associated with risk of CIN3 or cervical cancer. Former smokers, women who smoked less than one pack of cigarettes per day, and women who smoked one or more packs per day had crude RRs for CIN3 or cervical cancer for the entire follow-up period of 2.1 (95% CI = 1.1 to 3.9), 2.2 (95% CI = 1.2 to 4.2), and 2.9 (95% CI = 1.5 to 5.6), respectively, compared with never smokers. In the multivariable model, former smokers, women who smoked less than one pack/day, and women who smoked one or more packs/day had RRs of 3.3 (95% CI = 1.6 to 6.7), 2.9 (95% CI = 1.4 to 6.1), and 4.3 (95% CI = 2.0 to 9.3), respectively, for CIN3 or cervical cancer compared with never smokers. Conclusions: Smoking is associated with an increased risk of invasive cervical cancer in women who are infected with oncogenic HPV. Subsequent studies should examine the role of smoking in the multistage pathogenesis of cervical cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. E. Castle, C. Meyers, S. Alam, and M. J. Conway How Does Tobacco Smoke Contribute to Cervical Carcinogenesis? J. Virol., June 15, 2008; 82(12): 6084 - 6086. [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Clifford, H.-R. Shin, J.-K. Oh, T. Waterboer, Y.-H. Ju, S. Vaccarella, W. Quint, M. Pawlita, and S. Franceschi Serologic Response to Oncogenic Human Papillomavirus Types in Male and Female University Students in Busan, South Korea Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1874 - 1879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Gunnell, T. N. Tran, A. Torrang, P. W. Dickman, P. Sparen, J. Palmgren, and N. Ylitalo Synergy between Cigarette Smoking and Human Papillomavirus Type 16 in Cervical Cancer In situ Development Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2141 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Minkoff, L. S. Xian, D. H. Watts, R. Leighty, R. Hershow, J. Palefsky, R. Tuomala, N. Neu, C. D. Zorrilla, M. Paul, et al. Relationship of Pregnancy to Human Papillomavirus Among Human Immunodeficiency Virus-Infected Women. Obstet. Gynecol., October 1, 2006; 108(4): 953 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Koshiol, J. Schroeder, D. J. Jamieson, S. W. Marshall, A. Duerr, C. M. Heilig, K. V. Shah, R. S. Klein, S. Cu-Uvin, P. Schuman, et al. Smoking and Time to Clearance of Human Papillomavirus Infection in HIV-Seropositive and HIV-Seronegative Women Am. J. Epidemiol., July 15, 2006; 164(2): 176 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Shew, J. D. Fortenberry, W. Tu, B. E. Juliar, B. E. Batteiger, B. Qadadri, and D. R. Brown Association of Condom Use, Sexual Behaviors, and Sexually Transmitted Infections With the Duration of Genital Human Papillomavirus Infection Among Adolescent Women Arch Pediatr Adolesc Med, February 1, 2006; 160(2): 151 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lau and E. L. Franco Management of low-grade cervical lesions in young women Can. Med. Assoc. J., September 27, 2005; 173(7): 771 - 774. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Khan, P. E. Castle, A. T. Lorincz, S. Wacholder, M. Sherman, D. R. Scott, B. B. Rush, A. G. Glass, and M. Schiffman The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice J Natl Cancer Inst, July 20, 2005; 97(14): 1072 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Richardson, M. Abrahamowicz, P.-P. Tellier, G. Kelsall, R. du Berger, A. Ferenczy, F. Coutlee, and E. L. Franco Modifiable Risk Factors Associated with Clearance of Type-Specific Cervical Human Papillomavirus Infections in a Cohort of University Students Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1149 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. McIntyre-Seltman, P. E. Castle, R. Guido, M. Schiffman, C. M. Wheeler, and for The ALTS Group Smoking Is a Risk Factor for Cervical Intraepithelial Neoplasia Grade 3 among Oncogenic Human Papillomavirus DNA-Positive Women with Equivocal or Mildly Abnormal Cytology Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1165 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Heselmeyer-Haddad, K. Sommerfeld, N. M. White, N. Chaudhri, L. E. Morrison, N. Palanisamy, Z. Y. Wang, G. Auer, W. Steinberg, and T. Ried Genomic Amplification of the Human Telomerase Gene (TERC) in Pap Smears Predicts the Development of Cervical Cancer Am. J. Pathol., April 1, 2005; 166(4): 1229 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Shields, L. A. Brinton, R. D. Burk, S. S. Wang, S. J. Weinstein, R. G. Ziegler, Y. Y. Studentsov, M. McAdams, and M. Schiffman A Case-Control Study of Risk Factors for Invasive Cervical Cancer among U.S. Women Exposed to Oncogenic Types of Human Papillomavirus Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1574 - 1582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Harris, S. L. Kulasingam, N. B. Kiviat, C. Mao, S. N. Agoff, Q. Feng, and L. A. Koutsky Cigarette Smoking, Oncogenic Human Papillomavirus, Ki-67 Antigen, and Cervical Intraepithelial Neoplasia Am. J. Epidemiol., May 1, 2004; 159(9): 834 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Heselmeyer-Haddad, V. Janz, P. E. Castle, N. Chaudhri, N. White, K. Wilber, L. E. Morrison, G. Auer, F. H. Burroughs, M. E. Sherman, et al. Detection of Genomic Amplification of the Human Telomerase Gene (TERC) in Cytologic Specimens as a Genetic Test for the Diagnosis of Cervical Dysplasia Am. J. Pathol., October 1, 2003; 163(4): 1405 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Molano, A. van den Brule, M. Plummer, E. Weiderpass, H. Posso, A. Arslan, C. J. L. M. Meijer, N. Munoz, and S. Franceschi Determinants of Clearance of Human Papillomavirus Infections in Colombian Women with Normal Cytology: A Population-based, 5-Year Follow-up Study Am. J. Epidemiol., September 1, 2003; 158(5): 486 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schiffman and S. K. Kjaer Chapter 2: Natural History of Anogenital Human Papillomavirus Infection and Neoplasia J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 14 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Castellsague and N. Munoz Chapter 3: Cofactors in Human Papillomavirus Carcinogenesis--Role of Parity, Oral Contraceptives, and Tobacco Smoking J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 20 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Franco Chapter 13: Primary Screening of Cervical Cancer With Human Papillomavirus Tests J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 89 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wacholder Chapter 18: Statistical Issues in the Design and Analysis of Studies of Human Papillomavirus and Cervical Neoplasia J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 125 - 130. [Abstract] [Full Text] [PDF]
|
|